Cannabis Rescheduling Hearings Reopen Old Wounds for Battered MSO Investors
The DEA's expedited administrative hearing on Schedule III rescheduling, which began June 29, 2026, represents the most concrete regulatory movement the U.S. cannabis industry has seen in years.
